2025-521502-18-00CompletedPhase 1
A Trial to Determine if Quabodepistat is Processed Differently in Adults with Reduced Liver Function Compared to Adults with Normal Liver Function
Source: EU CTIS (euclinicaltrials.eu) · Last updated 5 Mar 2026
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 16 Jun 2025
- Start date
- 13 Nov 2025
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization Inc.
- Diseases
- Tuberculosis
- EU CT number
- 2025-521502-18-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 32
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical Center Comac Medical Ltd. | Sofia | Bulgaria | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.